AzTrials
AzTrials

Post Traumatic Stress Disorder (PTSD)NCT04086654

Psychometric Properties of the International Trauma Interview (ITI) for ICD-11 PTSD and CPTSD

A study testing International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German version in people with Post Traumatic Stress Disorder (PTSD) and Complex Post-Traumatic Stress Disorder (CPTSD), run by University of Zurich at 1 site in Switzerland.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex… Read more about this study

Who is it for?
Ages 18 to 99 years
What is being tested?
International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German version
Could I receive a placebo?
No, everyone receives an active treatment
How many people
77 participants
Where
1 siteSwitzerland
Study dates
2 Mar 2020to 15 Oct 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 99 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study-specific Inclusion criteria

  • Structured diagnostic procedures upon hospital entry not yet started, except for orienting assessments
  • Able to give informed consent as documented by signature
  • Able to understand and communicate in German Exclusion criteria
  • Clinical signs for impaired cognitive abilities
  • Other contraindications to undergo the clinical interview

Trial locations and contacts

1 site in 1 country.

Switzerland1 site
  • Integrierte Psychiatrie Winterthur, Spezialstation für Traumafolgestörungen

    Winterthur, Canton of Zurich, 8400

Other trials in Switzerland

About this study

The aim of the project is to evaluate the psychometric properties (e.g. validity, reliability) of the International Trauma Interview (ITI) - German version. The ITI is a structured clinical interview that corresponds to the ICD-11 criteria for diagnosing both posttraumatic stress disorder (PTSD) and complex posttraumatic stress disorder (CPTSD).

Eligible participants from psychiatric inpatient and outpatient facilities in Switzerland who have provided informed will complete various self-report measures about trauma-related mental health complaints. In addition, the ITI will be conducted by a trained clinician. Lastly, information from the medical chart will be further used for scientific purpose. The overall assessment will take approximately 1-2 hours to complete.

Being tested
International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German version
Medical subject headings
Stress Disorders, Post-Traumatic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German versionDiagnostic test

    The ITI consists of 18 items and for each symptom, standardized questions as well as probes are presented. A trained professional rates both symptom frequency and intensity, which are converted into an overall index of symptom severity. A diagnosis of PTSD/CPTSD is established by applying the ICD-11 diagnostic rules. It takes approximately 30-60 minutes to administer.

Study groups in NCT04086654
Study groupRoleWhat they receive
International Trauma Interview (ITI)OtherNot described
Receives: Diagnostic Test: International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German version

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. International Trauma Interview (ITI)

    Measured: Up to two weeks upon psychiatric ward entry

  2. Life Event Checklist DSM-5

    Measured: Up to two weeks upon psychiatric ward entry

Secondary outcomes (5)
  1. Beck Depression Inventory II

    Measured: Up to seven days upon psychiatric ward entry

  2. Brief Symptom Checklist

    Measured: Up to seven days upon psychiatric ward entry

  3. Impact of Event Scale Revised Version

    Measured: Up to seven days upon psychiatric ward entry

  4. PTSD Checklist for DSM-5

    Measured: Up to seven days upon psychiatric ward entry

  5. Borderline Symptom List

    Measured: Up to seven days upon psychiatric ward entry

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Sep 2019
  2. Study start2 Mar 2020
  3. Primary completion15 Oct 2021
  4. Study completion15 Oct 2021

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
77 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04086654
Sponsor's protocol ID
ITI Project
Status last verified
Nov 2022
First submitted
9 Sep 2019
Last updated
22 Nov 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing International Trauma Interview (ITI) for ICD-11 PTSD and Complex PTSD - German version in people with Post Traumatic Stress Disorder (PTSD) and Complex Post-Traumatic Stress Disorder (CPTSD), run by University of Zurich at 1 site in Switzerland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Switzerland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

International Trauma Interview (ITI) (time frame: Up to two weeks upon psychiatric ward entry). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in